Data Requirements for Patenting Biotech/Pharma Inventions in China and the EU

In Webinars

1 July, 2020

This interactive webinar considers the filing and post-filing data requirements for biotechnology and pharmaceutical-related inventions in China and the EU. Xiaofan Chen, Hai Liu and Helle Friis Svenstrup from AWA’s Asian and European offices explain the minimum data requirements during filing and also the criteria for supplementary data. They also consider the use of post-grant data as evidence during invalidation proceedings. Understanding the differences between the European and Chinese regimes is essential for applicants to be successful.

 

 

 

You may also be interested in:

Patenting Antibody and Cell Therapies – What to Do and What Not to Do

Antibody drugs and cell therapies are at the heart of new biotechnology science. Not only do they show great

Read more...
SMEs Webinar

Easing the Pain for SMEs – Effectiveness of External IP Counsel

  In this interactive webinar moderated by Cathrin Johansson, panellists Malin Wennberg and Anneli Jönsson take a closer look

Read more...
boost for brand owners

Boost for brand owners as Denmark introduces Product and Market Surveillance Law

On 4 June 2020 the Danish Parliament passed the Product and Market Surveillance Law, which concerns product safety and

Read more...

Mobile Sliding Menu